Literature DB >> 2059412

Pathogenetic basis of vascular dementia.

A Wallin1, K Blennow.   

Abstract

Vascular dementia (VAD) was studied with reference to pathogenetic aspects, especially the importance of brain infarcts. A VAD diagnosis was chosen when the patients showed dementia in combination with transitory ischemic attacks (TIA), stroke episodes, or other pronounced vascular diseases judged to be causally related to the dementia. Computed tomography (CT) white matter lesions were shown to occur frequently (85%); a pronounced decrease in myelin lipids was common in subcortical white matter; a fronto-subcortical symptom complex was the prevailing clinical pattern; and an overall increased albumin ratio without relation to TIA/stroke was noted, indicating blood-brain barrier (BBB) dysfunction. When infarcts were present, they appeared to be endpoint manifestations of the vascular pathology rather than the cause of the disease. Today, thromboembolism with multiple cerebral infarcts is considered more or less the only pathogenetic substrate of VAD, with multi-infarct dementia (MID) as its clinical counterpart. Our findings suggest that subcortical white matter changes are another important VAD substrate.

Entities:  

Mesh:

Year:  1991        PMID: 2059412     DOI: 10.1097/00002093-199100520-00006

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  9 in total

1.  Clinical features of leuko-araiosis.

Authors:  S Tarvonen-Schröder; M Röyttä; I Räihä; T Kurki; T Rajala; L Sourander
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-04       Impact factor: 10.154

2.  Neuropathological assessment of the lesions of significance in vascular dementia.

Authors:  M M Esiri; G K Wilcock; J H Morris
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-12       Impact factor: 10.154

3.  Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia.

Authors:  H Tohgi; T Abe; M Kimura; M Saheki; S Takahashi
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

4.  Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study.

Authors:  N Andreasen; E Vanmechelen; A Van de Voorde; P Davidsson; C Hesse; S Tarvonen; I Räihä; L Sourander; B Winblad; K Blennow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-03       Impact factor: 10.154

Review 5.  Clinical evaluation of the ICD-10 criteria for vascular dementia.

Authors:  T Wetterling; R D Kanitz; K J Borgis
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

Review 6.  Homocysteine and Mild Cognitive Impairment: Are These the Tools for Early Intervention in the Dementia Spectrum?

Authors:  Z Ansari
Journal:  J Nutr Health Aging       Date:  2016-02       Impact factor: 4.075

7.  Vitamin D, Homocysteine, and Folate in Subcortical Vascular Dementia and Alzheimer Dementia.

Authors:  Rita Moretti; Paola Caruso; Matteo Dal Ben; Corrado Conti; Silvia Gazzin; Claudio Tiribelli
Journal:  Front Aging Neurosci       Date:  2017-05-30       Impact factor: 5.750

8.  Nonalcoholic Fatty Liver Disease and Altered Neuropsychological Functions in Patients with Subcortical Vascular Dementia.

Authors:  Rita Moretti; Mauro Giuffré; Lory Saveria Crocè; Silvia Gazzin; Claudio Tiribelli
Journal:  J Pers Med       Date:  2022-07-05

Review 9.  An Iatrogenic Model of Brain Small-Vessel Disease: Post-Radiation Encephalopathy.

Authors:  Rita Moretti; Paola Caruso
Journal:  Int J Mol Sci       Date:  2020-09-05       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.